Biosimilars Will Star at ACR

24-10-2013 MedPage TodayComments (0)


The Affordable Care Act created a streamlined approval pathway for biosimilars that can demonstrate that there are no "clinically meaningful differences between the biosimilar and the approved biological product in terms of the safety, purity, and ...

Read more on MedPage Today

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top